ATE549012T1 - Pharmazeutische zusammensetzung mit s- nitrosoglutathion und polysaccharid - Google Patents

Pharmazeutische zusammensetzung mit s- nitrosoglutathion und polysaccharid

Info

Publication number
ATE549012T1
ATE549012T1 AT08839029T AT08839029T ATE549012T1 AT E549012 T1 ATE549012 T1 AT E549012T1 AT 08839029 T AT08839029 T AT 08839029T AT 08839029 T AT08839029 T AT 08839029T AT E549012 T1 ATE549012 T1 AT E549012T1
Authority
AT
Austria
Prior art keywords
polysaccharide
nitrosoglutathione
pharmaceutical composition
composition containing
type
Prior art date
Application number
AT08839029T
Other languages
English (en)
Inventor
Zsombor Lacza
Istvan Hornyak
Original Assignee
Pharmagenix Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmagenix Ag filed Critical Pharmagenix Ag
Application granted granted Critical
Publication of ATE549012T1 publication Critical patent/ATE549012T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT08839029T 2007-10-17 2008-10-16 Pharmazeutische zusammensetzung mit s- nitrosoglutathion und polysaccharid ATE549012T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUP0700678 2007-10-17
PCT/HU2008/000124 WO2009050527A1 (en) 2007-10-17 2008-10-16 Pharmaceutical composition comprising s-nitrosoglutathione and polysaccharide

Publications (1)

Publication Number Publication Date
ATE549012T1 true ATE549012T1 (de) 2012-03-15

Family

ID=89621292

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08839029T ATE549012T1 (de) 2007-10-17 2008-10-16 Pharmazeutische zusammensetzung mit s- nitrosoglutathion und polysaccharid

Country Status (8)

Country Link
US (1) US20100292326A1 (de)
EP (1) EP2197417B1 (de)
AT (1) ATE549012T1 (de)
DK (1) DK2197417T3 (de)
ES (1) ES2383846T3 (de)
PL (1) PL2197417T3 (de)
PT (1) PT2197417E (de)
WO (1) WO2009050527A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU0800031D0 (en) * 2008-01-16 2008-03-28 Biotech Hungary Kutato Es Fejl Method for stabilization of s-nitrosoglutathione and composition prepared by the same
CN102140171B (zh) * 2010-12-22 2013-07-10 南开大学 用作非病毒基因载体材料的谷胱甘肽修饰壳聚糖共聚物及其制备和应用
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
EP2764876A1 (de) 2013-02-11 2014-08-13 Lacerta Technologies Inc. Knochenersatzmaterial mit biologisch aktiver Beschichtung
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
KR101555523B1 (ko) * 2014-02-28 2015-09-25 부산대학교 산학협력단 산화질소 방출성 상처치료 필름 및 이의 제조방법
US20220296532A1 (en) * 2019-10-07 2022-09-22 Insense Limited Composition for delivering nitric oxide to skin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207855B1 (en) 1998-06-23 2001-03-27 Duke University Medical Center Stable no-delivering compounds
ES2147162B1 (es) 1999-01-27 2001-03-16 Lacer Sa "s-nitrosotioles como agentes para el tratamiento de disfunciones circulatorias".
US20020002136A1 (en) * 2000-06-28 2002-01-03 Hebert Rolland F. Salts of glutathione
HU0800031D0 (en) * 2008-01-16 2008-03-28 Biotech Hungary Kutato Es Fejl Method for stabilization of s-nitrosoglutathione and composition prepared by the same

Also Published As

Publication number Publication date
PT2197417E (pt) 2012-06-20
ES2383846T3 (es) 2012-06-26
WO2009050527A1 (en) 2009-04-23
EP2197417B1 (de) 2012-03-14
EP2197417A1 (de) 2010-06-23
DK2197417T3 (da) 2012-06-25
PL2197417T3 (pl) 2012-08-31
US20100292326A1 (en) 2010-11-18

Similar Documents

Publication Publication Date Title
ATE549012T1 (de) Pharmazeutische zusammensetzung mit s- nitrosoglutathion und polysaccharid
BR112012016021A8 (pt) Formulações estáveis para liofilização de partículas terapêuticas
WO2011079279A3 (en) Nanoconjugates and nanoconjugate formulations
GB2475666A (en) Polymers derived from benzobis (silolothiophene) and their use as organic semiconductors
PH12019501199A1 (en) Calcium lactate compositions and methods of use
MX2009011247A (es) Nanoparticulas que comprenden una ciclodextrina y una molecula biologicamente activa y sus aplicaciones.
EP4616907A3 (de) Weichgewebefüller
BR112018001978A2 (pt) composição farmacêutica compreendendo fibras obtidas de forma eletro-hidrodinâ¬mica, composição com tempo de permanência melhorado sobre o local de aplicação
EP4516101A3 (de) Zusammensetzungen und verwendungen antimikrobieller materialien mit gewebekompatiblen eigenschaften
TR200806298A2 (tr) Farmasötik formülasyon
PE20142325A1 (es) Composiciones derivadas de la quitosana
BR112012023455A2 (pt) composição de material, preparação e uso da mesma
ATE543871T1 (de) Zusammensetzung mit einem halogenierten vinylpolymer und einem copolymer mit assoziativen gruppen
BR112017013057A2 (pt) sistemas de polímero curável por umidade com base em uma mistura de poliéteres polissililados
BR112015031329A2 (pt) composições compreendendo ciclodextrina e ácido hialurônico reticulado
BR112014032627A8 (pt) Pró-fármacos de rebamipida, método para produzir o mesmo, e uso do mesmo
MX382580B (es) Formulaciones de liberación inmediata disuasivas de abuso que comprenden polisacáridos no celulósicos.
BR112017002569A2 (pt) composições adesivas compreendendo polímeros à base de olefina funcionalizados de baixo peso molecular
BR112017027625A2 (pt) matriz polimérica adesiva hemostática altamente eficaz
EA201070378A1 (ru) Фармацевтические составы орлистата
EA201390979A1 (ru) Композиции бензимидазолов с модифицированным высвобождением
BRPI0821948A2 (pt) polìmero funcionalizado e métodos para preparo e uso
EA200802307A1 (ru) Бинарные смеси гиалуроновой кислоты и их терапевтическое применение
BR112015009453A2 (pt) composição farmacêutica estável de peg-interferona alfa-2b
BRPI0906874A2 (pt) método para estabilização de s-nitrosoglutationa e composição preparada através do mesmo